FILTER
Refine your search with the following facets to narrow down your results.
- breast cancer 6
- vaccines 6
- Spain 5
- herpes simplex 5
- pancreatic cancer 5
- Switzerland 4
- cancer therapy 4
- chemotherapy 4
- milestone payments 4
- viruses 4
- Carrier 3
- acute myeloid leukemia 3
- biotechnology 3
- colorectal cancer 3
- dendritic cells 3
- diseases 3
- drug development 3
- glioma 3
- license agreements 3
- metastases 3
- oncolytic viruses 3
- personnel changes 3
- rheumatoid arthritis 3
- Amgen 2
- Astellas Pharma 2
- Hoechst 2
- Nycomed 2
- Orphan Drug Designation 2
- T-cell receptors 2
- USA 2
- Veregen 2
- antigens 2
- cancer 2
- cell therapies 2
- immunology 2
- monoclonal antibodies 2
- oncology 2
- phase I/II studies 2
- process development 2
- radiotherapy 2
- restructuring 2
- services 2
- supervisory board 2
- ASCO 1
- Albania 1
- Arzneimittel 1
- Belgium 1
- BioNTech 1
- Biotechnica 1
- Bosnia and Herzegowina 1
- Canada 1
- Colombia 1
- Croatia (Hrvatska) 1
- Deutsche Messe 1
- Formation 1
- HASE 1
- HPV 1
- Hormone 1
- Japan 1
- Leuprolide 1
- Life Sciences 1
- Luxembourg 1
- Macedonia 1
- Mexico 1
- Mitsui 1
- Netherlands 1
- Pharmaceutics 1
- Portugal 1
- Reissert Compound 1
- Roche Diagnostics 1
- Sanofi Pasteur 1
- Sanofi-aventis 1
- Serbia 1
- Slovenia 1
- Solvay 1
- T cells 1
- TEVA 1
- Taiwan 1
- Teva Pharmaceutical 1
- Venezuela 1
- acute myocardial infarction 1
- adenocarcinoma 1
- adoptive T cell therapy 1
- angiogenesis 1
- anti-infectives 1
- antibodies 1
- appointments 1
- bioavailability 1
- biology 1
- biopharmaceuticals 1
- brain tumors 1
- business development 1
- cancer vaccines 1
- chronic diseases 1
- concrete 1
- MediGene AG 61
- Astellas Pharma Europe Ltd. 2
- Catherex, Inc. 2
- European Patent Office (EPO) / Europäisches Patentamt (EPA) 2
- Medicines and Healthcare Products Regulatory Agency (MHRA) 2
- Amgen Inc. 1
- Astellas Pharma Inc. 1
- Avidex Ltd. 1
- BioNTech SE 1
- Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) 1
- Celltrion, Inc 1
- Deutsches Krebsforschungszentrum - DKFZ 1
- European Medicines Agency (EMA) 1
- GlaxoSmithKline plc (GSK) 1
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH 1
- Juste S.A.Q.F. 1
- Juvenile Diabetes Research Foundation (JDRF) 1
- National Cancer Institute (NCI) 1
- Pharmanova d.o.o. 1
- Pierre Fabre Médicament 1
- Sanofi Pasteur SA 1
- Solvay Pharmaceuticals SA 1
- Solvay SA 1
- Syncore Biotechnology Co., Ltd 1
- Teva Pharmaceuticals Industries Ltd. 1
- The Johns Hopkins University 1
- U. S. Food and Drug Administration (FDA) 1
- University of Alabama, Birmingham (UAB) 1
- Will-Pharma Belgium 1
- sanofi-aventis Groupe 1
61 Current news of MediGene
FILTERS
Refine your search with the following facets to narrow down your results.
- breast cancer 6
- vaccines 6
- Spain 5
- herpes simplex 5
- pancreatic cancer 5
- Switzerland 4
- cancer therapy 4
- chemotherapy 4
- milestone payments 4
- viruses 4
- Carrier 3
- acute myeloid leukemia 3
- biotechnology 3
- colorectal cancer 3
- dendritic cells 3
- diseases 3
- drug development 3
- glioma 3
- license agreements 3
- metastases 3
- oncolytic viruses 3
- personnel changes 3
- rheumatoid arthritis 3
- Amgen 2
- Astellas Pharma 2
- Hoechst 2
- Nycomed 2
- Orphan Drug Designation 2
- T-cell receptors 2
- USA 2
- Veregen 2
- antigens 2
- cancer 2
- cell therapies 2
- immunology 2
- monoclonal antibodies 2
- oncology 2
- phase I/II studies 2
- process development 2
- radiotherapy 2
- restructuring 2
- services 2
- supervisory board 2
- ASCO 1
- Albania 1
- Arzneimittel 1
- Belgium 1
- BioNTech 1
- Biotechnica 1
- Bosnia and Herzegowina 1
- Canada 1
- Colombia 1
- Croatia (Hrvatska) 1
- Deutsche Messe 1
- Formation 1
- HASE 1
- HPV 1
- Hormone 1
- Japan 1
- Leuprolide 1
- Life Sciences 1
- Luxembourg 1
- Macedonia 1
- Mexico 1
- Mitsui 1
- Netherlands 1
- Pharmaceutics 1
- Portugal 1
- Reissert Compound 1
- Roche Diagnostics 1
- Sanofi Pasteur 1
- Sanofi-aventis 1
- Serbia 1
- Slovenia 1
- Solvay 1
- T cells 1
- TEVA 1
- Taiwan 1
- Teva Pharmaceutical 1
- Venezuela 1
- acute myocardial infarction 1
- adenocarcinoma 1
- adoptive T cell therapy 1
- angiogenesis 1
- anti-infectives 1
- antibodies 1
- appointments 1
- bioavailability 1
- biology 1
- biopharmaceuticals 1
- brain tumors 1
- business development 1
- cancer vaccines 1
- chronic diseases 1
- concrete 1
- MediGene AG 61
- Astellas Pharma Europe Ltd. 2
- Catherex, Inc. 2
- European Patent Office (EPO) / Europäisches Patentamt (EPA) 2
- Medicines and Healthcare Products Regulatory Agency (MHRA) 2
- Amgen Inc. 1
- Astellas Pharma Inc. 1
- Avidex Ltd. 1
- BioNTech SE 1
- Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) 1
- Celltrion, Inc 1
- Deutsches Krebsforschungszentrum - DKFZ 1
- European Medicines Agency (EMA) 1
- GlaxoSmithKline plc (GSK) 1
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH 1
- Juste S.A.Q.F. 1
- Juvenile Diabetes Research Foundation (JDRF) 1
- National Cancer Institute (NCI) 1
- Pharmanova d.o.o. 1
- Pierre Fabre Médicament 1
- Sanofi Pasteur SA 1
- Solvay Pharmaceuticals SA 1
- Solvay SA 1
- Syncore Biotechnology Co., Ltd 1
- Teva Pharmaceuticals Industries Ltd. 1
- The Johns Hopkins University 1
- U. S. Food and Drug Administration (FDA) 1
- University of Alabama, Birmingham (UAB) 1
- Will-Pharma Belgium 1
- sanofi-aventis Groupe 1